Novo Nordisk A/S - The Final Phase 3a Trial for IDegLira Completed, and FIAsp Approved for Phase 3 Development

Published: Dec 19, 2012

BAGSVAERD, DENMARK--(Marketwire - December 19, 2012) - Company Announcement No 83 2012:

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE


Novo Nordisk A/S
Novo Alle , DK-2880
Bagsvaerd, Danmark
*T. Tlf. +45 44 44 88 88
*F. Fax +45 44 44 49 05

Back to news